Status:
COMPLETED
Artificial Intelligence-assisted Colonoscopy on Detection of Missed Proximal Lesions
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Tan Tock Seng Hospital
Institute of Gastroenterology and Hepatology, Vietnam
Conditions:
Colon Adenoma
Colon Polyp
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
This is a prospective multi-center randomized study is to determine whether the use of artificial intelligence (AI)-assistance could reduce the miss rates of polyps and adenomas in the proximal colon ...
Detailed Description
Centers 1. Queen Mary Hospital, Hong Kong, China (Co-ordinating Center) 2. Tan Tock Seng Hospital, Singapore, Singapore 3. Institute of Gastroenterology and Hepatology, Vietnam Union of Science and T...
Eligibility Criteria
Inclusion
- All adult patients, aged 40 or above, undergoing outpatient colonoscopy in the participating centers will be recruited
Exclusion
- history of inflammatory bowel disease
- history of colorectal cancer
- previous bowel resection (apart from appendectomy)
- Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes
- bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2022
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT04294355
Start Date
March 1 2021
End Date
April 15 2022
Last Update
April 21 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, China
2
Tan Tock Seng Hospital
Singapore, Singapore
3
Institute of Gastroenterology and Hepatology
Hanoi, Vietnam, 0